Splenocytes from mRIPO-treated animals provoked varied tumor-specific lymphocyte states as evidenced by expanded baseline and antigen-specific Th1- (IFNγ, TNF), Th2- (IL-5), and Th9- (IL-9) associated cytokine secretion. Here, IL5 is linked to neoplasm.